AKT1 and glioblastoma: Down‐regulation of EPHB3 and TNFAIP3 activated the PI3K/Akt and NF‐κB signaling pathway, enhanced proliferation and inhibited apoptosis of glioblastoma cells, and eventually enhanced the TMZ resistance in glioblastoma.